Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors

Peking University

Status: Enrolling

Conditions: Breast Cancer; Aromatase Inhibitors; Endocrine Therapy; Depression; Anxiety; Pain; Sleep

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT05628077

yifeng

Details and patient eligibility

About

We obtained the occurrence of pain sensation, pain mood, sleep, etc. during endocrine therapy in breast cancer patients through telephone follow-up, and analyzed risk factors through artificial intelligence

Enrollment: 1,200 estimated patients

Sex: Female

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Breast cancer survivors on aromatase inhibitors

Exclusion criteria

• Advanced breast cancer

Trial design

1,200 participants in 2 patient groups

PAIN

Treatment:

Other: No intervention

NO PAIN

Treatment:

Other: No intervention